GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Rhino Biotech Ltd (OTCPK:RBRXF) » Definitions » Revenue

Rhino Biotech (Rhino Biotech) Revenue : $0.00 Mil (TTM As of Dec. 2020)


View and export this data going back to 2004. Start your Free Trial

What is Rhino Biotech Revenue?

Rhino Biotech's revenue for the six months ended in Dec. 2020 was $0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00 Mil. Rhino Biotech's Revenue per Share for the six months ended in Dec. 2020 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.


Rhino Biotech Revenue Historical Data

The historical data trend for Rhino Biotech's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhino Biotech Revenue Chart

Rhino Biotech Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Rhino Biotech Semi-Annual Data
Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Rhino Biotech's Revenue

For the Shell Companies subindustry, Rhino Biotech's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rhino Biotech's Revenue Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Rhino Biotech's Revenue distribution charts can be found below:

* The bar in red indicates where Rhino Biotech's Revenue falls into.



Rhino Biotech Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Revenue for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Rhino Biotech  (OTCPK:RBRXF) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Rhino Biotech Revenue Related Terms

Thank you for viewing the detailed overview of Rhino Biotech's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Rhino Biotech (Rhino Biotech) Business Description

Traded in Other Exchanges
N/A
Address
294 Heywood House, British West Indies, Anguilla, AIA
Rhino Biotech Ltd formerly Eurasia Energy Ltd is a shell company.
Executives
Nicholas W Baxter 10 percent owner 220 SPRINGFIELD ROAD, ABERDEEN, ABERDEENSHIRE, SCOTLAND X0 AB15 6AU
Graham Crabtree officer: Chief Financial Officer 294 HEYWOOD HOUSE SOUTH HILL 1A AI-2640
Roger Thomas director 22 HENDERSON ROAD LONDON X0 SW18 3RR
Velda King director, officer: President, C.E.O. SUITE C102 10000 NORTH 31ST AVENUE PHOENIX AZ 85051
Gerald R Tuskey director, officer: C.F.O., Secretary/Treasurer 570 GRANVILLE STREET SUITE 400 VANCOUVER BC A1 V6C 3P1

Rhino Biotech (Rhino Biotech) Headlines

From GuruFocus

Rhino Biotech to Present at the Planet Microcap Showcase

By ACCESSWIRE ACCESSWIRE 05-04-2022